<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Pain</journal-id><journal-title>Molecular Pain</journal-title><issn pub-type="epub">1744-8069</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1744-8069-1-22</article-id><article-id pub-id-type="pmid">16102169</article-id><article-id pub-id-type="doi">10.1186/1744-8069-1-22</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Genetic alteration of anxiety and stress-like behavior in mice lacking CaMKIV</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Shum</surname><given-names>Fanny WF</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>fanny.shum@utoronto.ca</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Ko</surname><given-names>Shanelle W</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>shana.ko@utoronto.ca</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Lee</surname><given-names>Yong-Seok</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>rhieys@snu.ac.kr</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Kaang</surname><given-names>Bong-Kiun</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>kaang@snu.ac.kr</email></contrib><contrib id="A5" corresp="yes" contrib-type="author"><name><surname>Zhuo</surname><given-names>Min</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>min.zhuo@utoronto.ca</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, M5S 1A8, Canada</aff><aff id="I2"><label>2</label>Department of Biological Sciences, College of Natural Sciences, Seoul National University, Seoul 151&#x02013;742, South Korea</aff><pub-date pub-type="collection"><year>2005</year></pub-date><pub-date pub-type="epub"><day>15</day><month>8</month><year>2005</year></pub-date><volume>1</volume><fpage>22</fpage><lpage>22</lpage><ext-link ext-link-type="uri" xlink:href="http://www.molecularpain.com/content/1/1/22"/><history><date date-type="received"><day>1</day><month>6</month><year>2005</year></date><date date-type="accepted"><day>15</day><month>8</month><year>2005</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2005 Shum et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2005</copyright-year><copyright-holder>Shum et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Shum WF Fanny fanny.shum@utoronto.ca </dc:author><dc:title> Genetic alteration of anxiety and stress-like behavior in mice lacking CaMKIV </dc:title><dc:date>2005</dc:date><dcterms:bibliographicCitation>Molecular Pain 1(1): 22-. (2005)</dcterms:bibliographicCitation><dc:identifier type="sici">1744-8069(2005)1:1&#x0003c;22&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1744-8069</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><p>Calcium-calmodulin-dependent protein kinase IV (CaMKIV) phosphorylates the major transcription factor cyclic AMP-response element binding protein (CREB), which plays a role in emotional behavior. Here, CaMKIV knockout mice (<italic>CaMKIV</italic><sup>-/-</sup>) were tested in a battery of stress and anxiety-related behavioral tests, to determine if CaMKIV plays a role in emotional behavior. <italic>CaMKIV</italic><sup>-/-</sup>exhibited a decrease in anxiety-like behavior in both the elevated plus maze and dark-light emergence tests when compared to wild-type mice. Both the acoustic startle response and prepulse inhibition of startle were decreased with the deletion of CaMKIV. In addition, <italic>CaMKIV</italic><sup>-/- </sup>mice displayed a lack of stress-induced analgesia following restraint or cold swim stress. Our results demonstrate a key role for CaMKIV in anxiety and stress-related behavior.</p></abstract><kwd-group><kwd>anxiety</kwd><kwd>CaMKIV</kwd><kwd>knockout mice</kwd><kwd>microarray</kwd><kwd>stress-induced analgesia</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>Calcium-calmodulin-dependent protein kinase IV (CaMKIV) plays a role in the activity-dependent phosphorylation of cyclic AMP-responsive element binding protein (CREB) and CRE modulator (CREM), which regulate the expression of genes involved in neuroplasticity [<xref ref-type="bibr" rid="B1">1</xref>], learning and memory [<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B4">4</xref>], emotional behavior [<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B7">7</xref>] and molecular changes induced by antidepressants [<xref ref-type="bibr" rid="B8">8</xref>]. Several protein kinase cascades regulate CREB function in the CNS [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B9">9</xref>], these include the cAMP signaling pathway and the Ca<sup>2+</sup>-calmodulin dependent protein kinase pathway. Among different Ca<sup>2+</sup>-dependent protein kinases, CaMKIV is detected predominantly in the nuclei of neurons [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>], therefore CaMKIV may play a unique role in the phosphorylation of CREB and in the regulation of neuronal gene expression [<xref ref-type="bibr" rid="B12">12</xref>].</p><p>CaMKIV is normally expressed in the amygdala and hippocampus, two brain structures involved in the regulation of anxiety and CaMKIV deficient mice exhibit defects in contextual and auditory fear memory [<xref ref-type="bibr" rid="B13">13</xref>]. A recent study reported that the CaMKIV signaling pathway may play a role in the excitation-mediated regulation of neuropeptides involved in the pathophysiology of anxiety in vitro [<xref ref-type="bibr" rid="B14">14</xref>]. However, molecular and physiological roles of CaMKIV in emotional behavior have yet to be investigated.</p><p>Previous studies have implicated that both CREB [<xref ref-type="bibr" rid="B5">5</xref>] and CREM [<xref ref-type="bibr" rid="B6">6</xref>] are activated by CaMKIV and both have been shown to play a role in emotional behavior. In the present study we wanted to determine if the deletion of CaMKIV would result in changes in anxiety and stress-related behaviors. Here we report that <italic>CaMKIV</italic><sup>-/- </sup>mice exhibit decreased anxiety-like behaviors in several anxiety paradigms and develop less stress-induced analgesia. Our results demonstrate a key role for CaMKIV in mediating changes in anxiety and stress-related behaviors.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><sec><title>Subjects</title><p>All subjects were 8&#x02013;12 weeks old male mice. The <italic>CaMKIV</italic><sup>-/- </sup>mice were derived as described [<xref ref-type="bibr" rid="B15">15</xref>] and bred for several generations on the C57BL/6 background (F12&#x02013;F16). While wild-type littermates were used in some experiments, C57BL/6 mice were purchased from Charles River to use as controls in others. We do not feel that this represents a problem with the genetics background since the CaMKIV transgenic line can be considered congenic with C57BL/6 and preliminary results showed that there was no difference in the behavior of wild-type littermates from C57BL/6 mice. Mice were housed on a 12-h light-dark schedule with food and water available <italic>ad libitum</italic>. All experiments were carried out in accordance with the rules and regulations of the Animal Care and Use Committee at the University of Toronto. All efforts were made to minimize the animal's suffering and to reduce the number of animals used. No visual difference between C57BL/6 and <italic>CaMKIV</italic><sup>-/- </sup>mice was noticeable and experiments were performed blind when possible.</p></sec><sec><title>Elevated plus-maze test</title><p>The elevated plus maze (Med Associates, St Albans, Vt) consists of two open arms and two closed arms situated opposite each other and separated by a 6 cm square center platform. Each runway is 6 cm wide and 35 cm long. The open arms have lips that are 0.5 cm high and the closed arms are surrounded on three sides by 20 cm walls. The floors and walls are black polypropylene. For each test, the animal was placed in the center square and allowed to move freely for five minutes. Open arm entries were defined as the mouse having all four paws onto the open arm. The number of entries and time spent in each arm was recorded.</p></sec><sec><title>Light/Dark box</title><p>The testing apparatus consisted of a rectangular Plexiglas box (44 &#x000d7; 8.5 &#x000d7; 25 cm) equally divided into a light, open topped, compartment connected by a door (17 cm in height) to a dark, closed topped, opaque compartment. Each mouse was placed in the light box and was allowed 10 sec to explore before the door to the dark box was opened. Each animal was tested for 10 min. The time spent in the light compartment and the number of light/dark transitions were recorded.</p></sec><sec><title>Dark-light emergence Task</title><p>The apparatus consisted of a black opaque plastic box (13 &#x000d7; 11 &#x000d7; 8.5 cm) with a small opening (3 &#x000d7; 6 cm) placed along one side of the open field evenly illuminated by white overhead lighting. The exit was faced out into the open field. Mice were individually placed into the box with the exit blocked for a 5 min habituation period. At the end of the habituation period, the exit was opened and the mice were allowed to freely explore the open field for 5 min. The latency to emerge from the box, time out of the box, time spent assessing the open field (scanning the open field with the head but less than four paws out of the box) and box/open field transitions were recorded.</p></sec><sec><title>Acoustic startle and prepulse inhibition (PPI)</title><p>Testing was conducted in a startle chamber from Med Associates (Med Associates Inc., St. Albans, VT). The startle chamber consists of a nonrestrictive Plexiglas cylinder (4.4 cm) in diameter, resting on a platform in a ventilated and sound attenuating chamber. A high-frequency speaker mounted behind the cylinder produced all the acoustic and prepulse stimuli. Mouse movements were detected and transduced by a stablimeter mounted under the cylinder and digitized and stored by a computer and interface assembly. Startling stimulus began at 80 dB and 1 ms readings were recorded to obtain the amplitude of the animal's startle or prepulse response to each stimulus. For acoustic startle, mice were acclimated in the chamber for 20 min and 80 trials of 80, 85, 90, 95, 100, 110 and 120 dB noise bursts were presented over a 45-min test session. The inter-trial interval varied randomly from 10 to 20 s, with an average of 15 s. For PPI, each test session consisted of 55 trials and was initiated with a 10-min acclimation period. Testing began after the initial exploratory behavior had diminished. Three different trial types were presented at random: 20 ms prepulse of 80, 90 or 100 dB, 100 ms before a startle noise burst (112 dB), startle noise burst (112 dB) alone and background noise alone. For both acoustic startle and PPI the background noise was at 70 dB.</p></sec><sec><title>Stress induced nociceptive tests</title><p>To induce stress, mice were forced to swim in water (10&#x000b0;C) for 3 min or were restrained for 30 min. Animals were individually restrained in small cylindrical tubes with a diameter slightly larger than a mouse's body. Responses to the hot-plate and tail-flick were measured at different time points up to 60 min after stress. Data are presented as the mean response latency (s) or maximum possible inhibition (MPI = (response latency &#x02013; baseline response latency)/ (cut-off time &#x02013; baseline response latency) &#x000d7; 100). The total effect of stress over time, the area under the curve (MPI <italic>versus </italic>time) was used.</p></sec><sec><title>GeneChip analysis</title><p>Total RNA was isolated from the forebrains of two C57BL/6 or <italic>CaMKIV</italic><sup>-/- </sup>mice using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) and purified with RNeasy mini kit (Qiagen). RNA quality was checked visually on an agarose gel and also by Agilent BioAnalyzer. Combined RNA was subjected to gene chip analysis (Affymetrix Mouse 430 2.0). First-strand synthesis, fragmentation, hybridization and washing were done according to GeneChip (Affymetrix Inc.) protocol. The array was scanned, and information was extracted using the GeneChip Expression Analysis program (Affymetrix) and analyzed using the GeneChip Operating System (GCOS, Affymetrix).</p></sec><sec><title>Reverse transcription-PCR analysis</title><p>First strand-cDNAs were synthesized from total RNA isolated from the forebrains of C57BL/6 and <italic>CaMKIV</italic><sup>-/- </sup>mice previously extracted for the GeneChip experiment (n = 2 for C57BL/6 and <italic>CaMKIV</italic><sup>-/- </sup>mice) using SuperScript III RT (Invitrogen) with oligo(dT) as a primer. The primers for RT-PCR were as follows: Oxytocin: sense, 5'-TTGCTGCCTGCTTGGCTTAC-3', antisense, 5'-TATTCCCAGAAAGTGGGCTC-3', arginine vasopressin: sense, 5'- ACACTACGCTCTCCGCTTGT-3', antisense, 5'- GGGCAGGTAGTTCTCCTCCT-3', Transthyretin: sense, 5'- ATGGTCAAAGTCCTGGATGC-3', antisense, 5'- CAGAGTCGTTGGCTGTGAAA-3', connexin 43: sense, 5'- GGACTGCTTCCTCTCACGTC-3', antisense, 5'- CAGCTTGTACCCAGGAGGAG-3' and synaptotagmin 1: sense 5'-CAATACTGCCATTCCCTCGT-3', antisense, 5'- GTAGCAGGCTCACCTTCCTG-3'. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was ampli?ed as an internal control by using the primer sets: sense, 5-AACGACCCCTTCATTGAC-3' antisense 5'-TCCACGACATACTCAGCAC-3'. PCR conditions were adjusted to be in a linear range of amplification.</p></sec><sec><title>Data analysis and Statistics</title><p>Results were analyzed by t-test, paired t-test, ONE-WAY ANOVA, TWO-WAY ANOVA followed by post-hoc Student-Newman-Keuls test to identify significant differences. All data are expressed as mean &#x000b1; S.E.M. In all cases, <italic>P </italic>&#x0003c; 0.05 was considered statistically significant.</p></sec></sec><sec><title>Results</title><sec><title>Decreased anxiety-related behaviors in <italic>CaMKIV</italic><sup>-/- </sup>mice</title><p>To determine if CaMKIV plays a role in the expression of anxiety-like behaviors, <italic>CaMKIV</italic><sup>-/- </sup>mice were tested in the elevated plus-maze, dark-light emergence test, light/dark box, acoustic startle and for the prepulse inhibition of startle. Previous studies showed that general locomotor activity was similar between <italic>CaMKIV</italic><sup>-/- </sup>mice in an open field when compared to wild-type mice, however, <italic>CaMKIV</italic><sup>-/- </sup>mice spent significantly more time exploring the center of the open field, which is indicative of a reduction in anxiety-like behavior [<xref ref-type="bibr" rid="B16">16</xref>]. To further assess anxious behaviors in <italic>CaMKIV</italic><sup>-/- </sup>mice, we used the elevated plus maze, which is a well-validated, conventional test for anxiety-related behavior in mice [<xref ref-type="bibr" rid="B17">17</xref>]. In this test, an increase in anxiety correlates with a decrease in exploration of the open arms of the maze. The number of entries into the closed arms or the total number of arm entries can be taken as a measure of locomotor activity. <italic>CaMKIV</italic><sup>-/- </sup>mice spent significantly more time in the open arms of the plus-maze (Fig. <xref ref-type="fig" rid="F1">1b</xref>; <italic>P </italic>&#x0003c; 0.001) and displayed an increase in the number of open arm visits (Fig. <xref ref-type="fig" rid="F1">1a</xref>; <italic>P </italic>&#x0003c; 0.01) when compared to wild-type mice. The number of entries into the closed arms (Fig. <xref ref-type="fig" rid="F1">1c</xref>; <italic>P </italic>&#x0003c; 0.05) and the total number of arm entries was also significantly increased (Fig. <xref ref-type="fig" rid="F1">1d</xref>; <italic>P </italic>&#x0003c; 0.001), suggesting an increase in locomotor activity.</p><fig position="float" id="F1"><label>Figure 1</label><caption><p>Decreased anxiety-like behavior in <italic>CaMKIV</italic><sup>-/- </sup>mice. <bold>a, </bold><italic>CaMKIV</italic><sup>-/- </sup>mice (n = 14 mice) displayed a significantly increased number of open arm entries (t(27) = -3.89, <italic>P </italic>&#x0003c; 0.001) compared with wild-type mice (n = 19 mice) in the elevated plus-maze. <bold>b, </bold>The percentage of time spent by <italic>CaMKIV</italic><sup>-/- </sup>mice in the open arms was significantly greater than wild-type mice (n = 19 mice, t(31) = -3.96, <italic>P </italic>&#x0003c; 0.01). <bold>c, d, </bold>There was a significant increase in the number of closed arm entries in CaMKIV<sup>-/- </sup>mice (n = 14 mice, t(27) = -2.21, <italic>P </italic>&#x0003c; 0.05) as well as total arm entries (n = 14 mice, t(27) = -3.90, <italic>P </italic>&#x0003c; 0.001) when compared to wild-type mice (n = 19 mice).</p></caption><graphic xlink:href="1744-8069-1-22-1"/></fig></sec><sec><title>Increased exploration in the dark-light emergence test</title><p>To strengthen our hypothesis that CaMKIV may play a role in the regulation of anxiety-like behaviors, we tested the performance of <italic>CaMKIV</italic><sup>-/- </sup>mice in the dark-light emergence test [<xref ref-type="bibr" rid="B18">18</xref>]. <italic>CaMKIV</italic><sup>-/- </sup>mice again displayed a significant decrease in anxiety-like behavior. We found that the overall time spent in the open field was significantly greater in <italic>CaMKIV</italic><sup>-/- </sup>mice (Fig. <xref ref-type="fig" rid="F2">2a</xref>; <italic>P </italic>&#x0003c; 0.05). We further examined changes in anxiety-related behavior using the light/dark box [<xref ref-type="bibr" rid="B19">19</xref>]. Anxiogenic agents decrease, while anxiolytic drugs increase the amount of time spent in the light half of the chamber [<xref ref-type="bibr" rid="B20">20</xref>]. The total time spent in the light compartment did not significantly differ between wild-type and <italic>CaMKIV</italic><sup>-/- </sup>mice (Fig. <xref ref-type="fig" rid="F2">2b</xref>). However, <italic>CaMKIV</italic><sup>-/- </sup>mice displayed a significant decrease in the number of light/dark transitions (Fig <xref ref-type="fig" rid="F2">2c</xref>; <italic>P </italic>&#x0003c; 0.05). Since this test is based on a mouse's natural aversion to brightly lit spaces, an overall decrease in exploration by <italic>CaMKIV</italic><sup>-/- </sup>mice may represent a reduction in conflict between the two chambers. Although <italic>CaMKIV</italic><sup>-/- </sup>mice did not display a consistent anxiety-like phenotype in the light/dark box paradigm, evidence suggests that similar rodent behavioral tests may measure different forms of anxiety-like behavior [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>]. Previous studies have found targeted gene mutations can produce anxiety-like phenotypes in some tests but not others [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>]. Therefore, the decrease in anxiety-like behavior seen in the elevated plus-maze and dark-light emergence test is likely to reliably represent the anxiety phenotype in <italic>CaMKIV</italic><sup>-/- </sup>mice.</p><fig position="float" id="F2"><label>Figure 2</label><caption><p>Dark-light emergence test and Light/Dark box paradigm. <bold>a, </bold>In the dark-light emergence test, <italic>CaMKIV</italic><sup>-/- </sup>mice (n = 7 mice) spent significantly more time outside the chamber compared to wild-type mice (n = 8 mice, t(13) = -2.65, <italic>P </italic>&#x0003c; 0.05,). <bold>b, </bold>In the light/dark box, no difference was seen between <italic>CaMKIV</italic><sup>-/- </sup>and wild-type mice in the time spent in the light compartment. <bold>c, </bold>However, wild-type mice (n = 10 mice) displayed an increase in the number of light/dark transitions compared with <italic>CaMKIV</italic><sup>-/- </sup>mice (n = 6, t(14) = 2.44, <italic>P </italic>&#x0003c; 0.05).</p></caption><graphic xlink:href="1744-8069-1-22-2"/></fig></sec><sec><title>Impaired startle and prepulse inhibition of startle</title><p>The acoustic startle response is elicited by a sudden loud acoustic stimulus and is characterized by a coordinated contraction of the muscles of the neck and extremities. The percent prepulse inhibition (PPI) is an index of sensorimotor gating. We examined the acoustic startle response and PPI in mice lacking CaMKIV. Consistent with a reduction in anxiety-like behaviors, <italic>CaMKIV</italic><sup>-/- </sup>mice displayed a decrease in baseline acoustic startle amplitudes (Fig. <xref ref-type="fig" rid="F3">3a</xref>; <italic>P </italic>&#x0003c; 0.05, <italic>P </italic>&#x0003c; 0.001, and <italic>P </italic>&#x0003c; 0.001 for 100 dB, 110 dB and 120 dB respectively). Similarly, <italic>CaMKIV</italic><sup>-/- </sup>mice showed a significant reduction in prepulse inhibition of the startle reflex at prepulse intensities of 90 and 100 dB (Fig <xref ref-type="fig" rid="F3">3b</xref>; <italic>P </italic>&#x0003c; 0.001 for both intensities). These results further support our hypothesis that CaMKIV may play a role in emotional behaviors.</p><fig position="float" id="F3"><label>Figure 3</label><caption><p>Decreased acoustic startle and PPI. <bold>a</bold>, Baseline startle amplitudes were significantly decreased at 100, 110 and 120 dB in <italic>CaMKIV</italic><sup>-/- </sup>mice (wild-type mice, n = 7 mice, <italic>CaMKIV</italic><sup>-/- </sup>n = 13 mice, at intensities of 100, 110, 120 dB, q = 3.44, <italic>P </italic>&#x0003c; 0.05, q = 5.02, <italic>P </italic>&#x0003c; 0.001, q = 6.55, <italic>P </italic>&#x0003c; 0.001 respectively). <bold>b</bold>, Prepulse inhibition of the startle reflex was significantly decreased at prepulse intensities of 90 and 100 dB (wild-type, n = 10 mice, <italic>CaMKIV</italic><sup>-/-</sup>, n = 18 mice, at intensities of 90 dB, q = 3.98, <italic>P </italic>&#x0003c; 0.01, 100 dB, q = 4.05, <italic>P </italic>&#x0003c; 0.01).</p></caption><graphic xlink:href="1744-8069-1-22-3"/></fig></sec><sec><title>CaMKIV plays a role in stress-induced analgesia</title><p>To determine if CaMKIV plays a role in stress-induced behavioral changes, <italic>CaMKIV</italic><sup>-/- </sup>and wild-type mice were tested for stress-induced analgesia after either restraint or swim stress. Consistent with previous studies [<xref ref-type="bibr" rid="B24">24</xref>], restraint stress induced analgesic effects in the tail-flick and hotplate tests in wild-type mice (Fig. <xref ref-type="fig" rid="F4">4a&#x02013;d</xref>). In contrast, <italic>CaMKIV</italic><sup>-/- </sup>mice failed to show any analgesia in both tests (<italic>P </italic>&#x0003c; 0.01 for both tests and area under the curve <italic>P </italic>&#x0003c; 0.001 and <italic>P </italic>&#x0003c; 0.05 for hotplate and tail-flick tests respectively). We can exclude the possibility that this is due to altered spinal nociceptive transmission since <italic>CaMKIV</italic><sup>-/- </sup>mice have unaltered baseline tail-flick and hotplate responses [<xref ref-type="bibr" rid="B13">13</xref>]. Similar results were obtained using the cold-swim stress test (Fig. <xref ref-type="fig" rid="F4">4e&#x02013;f</xref>; <italic>P </italic>&#x0003c; 0.05 comparisons of <italic>CaMKIV</italic><sup>-/- </sup>and wild-type mice using area under the curve). Here, we measured behavioral nociceptive responses on the hot-plate after animals were forced to swim in cold water. <italic>CaMKIV</italic><sup>-/- </sup>mice exhibited significantly reduced stress-induced analgesia when compared to wild-type controls. Taken together, these results suggest a role for CaMKIV in the regulation of stress-induced analgesia.</p><fig position="float" id="F4"><label>Figure 4</label><caption><p>Restraint and cold swim stress. <bold>a, c, </bold>Antinociceptive responses in the hot-plate (n = 8 wild-type mice, n = 9 <italic>CaMKIV</italic><sup>-/- </sup>mice, F(1,7) = 68.21, <italic>P </italic>&#x0003c; 0.01) and tail-flick test (F(1,7) = 13.59, <italic>P </italic>&#x0003c; 0.01) following restraint stress (30 min) was significantly decreased in <italic>CaMKIV</italic><sup>-/- </sup>mice. <bold>b, d</bold>, antinociceptive effect presented as area under the curve between 0 to 60 min after restraint stress in the hot-plate test (t(15) = 4.13, <italic>P </italic>&#x0003c; 0.001) and tail-flick test (t(15) = 2.86, <italic>P </italic>&#x0003c; 0.05) show a lack of stress-induced analgesia in <italic>CaMKIV</italic><sup>-/- </sup>mice. <bold>e, f</bold>, Similarly, hotplate responses after cold-swim test (n = 11 wild-type mice, n = 12 <italic>CaMKIV</italic><sup>-/- </sup>mice) was significantly reduced in <italic>CaMKIV</italic><sup>-/- </sup>mice (F(1,6) = 7.39, <italic>P </italic>&#x0003c; 0.05, area under the curve, t(21) = 2.26, <italic>P </italic>&#x0003c; 0.05)</p></caption><graphic xlink:href="1744-8069-1-22-4"/></fig></sec><sec><title>Changes in Stress/anxiety-related gene expression</title><p>Several studies show that altering CREB function can change anxiety-like behaviors [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B25">25</xref>] and since CaMKIV can directly modulate the activity of this major transcription factor, GeneChip analysis was performed on the forebrain of <italic>CaMKIV</italic><sup>-/- </sup>mice to uncover any changes in the expression levels of genes related to emotional behavior. We compared gene expression profiles between <italic>CaMKIV</italic><sup>-/- </sup>and wild-type mice and found 233 genes to be differentially expressed with lower expression levels in <italic>CaMKIV</italic><sup>-/- </sup>mice than in wild-type animals. We filtered out the top five anxiety/stress-related genes among down-regulated genes based on previous literature (Table <xref ref-type="table" rid="T1">1</xref>). Of particular interest, we found that the expression level of the neuropeptide oxytocin, which is known to mediate emotional behaviors such as social recognition [<xref ref-type="bibr" rid="B26">26</xref>], aggression [<xref ref-type="bibr" rid="B27">27</xref>] and stress-induced analgesia [<xref ref-type="bibr" rid="B24">24</xref>], was decreased in <italic>CaMKIV</italic><sup>-/- </sup>mice by more than twofold (2.83 fold, P &#x0003c; 0.05). To confirm this GeneChip data, reverse transcription-polymerase chain reaction (RT-PCR) was performed to measure the mRNA expression level of oxytocin in <italic>CaMKIV</italic><sup>-/- </sup>mice (Fig. <xref ref-type="fig" rid="F5">5</xref>). The results of the RT-PCR were consistent with those from GeneChip analysis, showing a decrease in oxytocin mRNA in <italic>CaMKIV</italic><sup>-/-</sup>. This suggests that, as an upstream regulator of CREB, CaMKIV may play a role in the regulation of anxiety-related genes such as oxytocin. Since oxytocin has been shown to mediate stress-induced analgesia in mice [<xref ref-type="bibr" rid="B24">24</xref>] and our gene expression analysis showed that the basal expression of oxytocin is reduced after the deletion of CaMKIV, this result is consistent with the lack of stress induced analgesia in <italic>CaMKIV</italic><sup>-/- </sup>mice.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Top 5 down-regulated anxiety-related gene expression in CaMKIV deficient mice</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center"><bold>Probe</bold></td><td align="left"><bold>Gene name</bold></td><td align="left"><bold>Accession</bold></td><td align="left"><bold>Symbol</bold></td><td align="left"><bold>LocusLink</bold></td><td align="left"><bold>Gene Description</bold></td></tr></thead><tbody><tr><td align="center">1450794_at</td><td align="left">Arginine vasopressin</td><td align="left">NM_009732.1</td><td align="left">Avp</td><td align="left">11998</td><td align="left">neurohypophysial peptide[35]</td></tr><tr><td align="center">1420556_at</td><td align="left">Oxytocin</td><td align="left">NM_011025.1</td><td align="left">Oxt</td><td align="left">18429</td><td align="left">neurohypophysial peptide[37]</td></tr><tr><td align="center">1451580_a_at</td><td align="left">Transthyretin</td><td align="left">BC024702.1</td><td align="left">Ttr</td><td align="left">22139</td><td align="left">transporter of thyroxine and vitamin A[41]</td></tr><tr><td align="center">1415801_at</td><td align="left">Connexin 43</td><td align="left">M63801.1</td><td></td><td align="left">14609</td><td align="left">subunit of gap junction channel[42]</td></tr><tr><td align="center">1421990_a</td><td align="left">Synaptotagmin 1</td><td align="left">NM_009306.1</td><td align="left">Syt1</td><td align="left">20979</td><td align="left">Ca2+ sensor for transmitter release[43]</td></tr></tbody></table></table-wrap><fig position="float" id="F5"><label>Figure 5</label><caption><p>Decreased oxytocin mRNA expression in <italic>CaMKIV</italic><sup>-/- </sup>mice. RT-PCR analysis revealed that the mRNA level of oxytocin was decreased in <italic>CaMKIV</italic><sup>-/- </sup>compared with wild-type mice. RT-PCR analysis confirmed the altered expression of oxytocin identified from GeneChip analysis.</p></caption><graphic xlink:href="1744-8069-1-22-5"/></fig></sec></sec><sec><title>Discussion</title><p>In the present study, we show that the genetic disruption of CaMKIV in mice results in a decrease in anxiety-like behavior and the abolishment of stress-induced analgesia. <italic>CaMKIV</italic><sup>-/- </sup>mice display reduced anxiety-like behaviors in the elevated plus-maze, dark-light emergence test, and in the acoustic startle reflex and PPI. Furthermore, these mice lack stress-induced analgesia induced by forced swim or restraint stress.</p><p>Several kinase cascades regulate CREB function in the CNS [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B9">9</xref>], these include the cAMP signaling pathway and Ca<sup>2+</sup>-calmodulin-dependent protein kinase pathway. The nuclear location of CaMKIV, its ability to phosphorylate CREB and its broad expression throughout forebrains areas suggests that CaMKIV may play an important role in higher brain function. CaMKIV may also play a role in CREB phosphorylation by modulating other kinase pathways. Studies in cell culture systems demonstrated the regulatory role of CaMKIV in MAP kinase and cAMP pathways [<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref>]. Disturbances in any of these pathways could potentially disrupt the control of CREB-mediated anxiety-related gene expression. Recent data showed the involvement of the CaMKIV cascade in antidepressant mechanisms [<xref ref-type="bibr" rid="B30">30</xref>]. In-vitro experiments have suggested a role for the CaMKIV signaling pathway in the excitation-mediated regulation of corticotrophin-releasing hormone (CRH) synthesis [<xref ref-type="bibr" rid="B14">14</xref>].</p><p>Previous studies of CREB mutant mice reported an increase in anxiety-like behavior in several behavioral paradigms including the elevated plus-maze, black and white box and open field [<xref ref-type="bibr" rid="B5">5</xref>]. Although mice lacking different isoforms of CREB responded differently to certain stressful situations, all CREB mutants displayed anxiety-like responses in all behavior models [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B25">25</xref>]. In another study, the CREB-related transcription factor CREM was shown to be involved in the control of anxiety-like behavior. CREM mutant mice were hyperactive in the open field but displayed reduced anxiety-like behaviors in the elevated plus-maze and zero maze [<xref ref-type="bibr" rid="B6">6</xref>]. From our data, <italic>CaMKIV</italic><sup>-/- </sup>mice displayed reduced anxiety-like behavior by spending more time in the open arms of the elevated plus-maze, which correlates with the phenotype of the CREM mutant mice. However, mice lacking CaMKIV did not show hyperlocomotor activities in the open field [<xref ref-type="bibr" rid="B15">15</xref>]. Our results show that <italic>CaMKIV</italic><sup>-/- </sup>mice made significantly more entries into the open and closed arms of the elevated plus-maze, suggesting an increase in locomotor activity. One explanation for this discrepancy may be because <italic>CaMKIV</italic><sup>-/- </sup>mice have less anxiety so they may spend more time exploring the anxious environment of the elevated plus maze when compared to wild-type mice. These results suggest that <italic>CaMKIV</italic><sup>-/- </sup>mice have a decrease in anxiety in the plus-maze compared to wild-type mice, and hint that CaMKIV may play a role in regulating levels of anxiety. Therefore, the contrasting phenotypes of between CaMKIV, CREB and CREM knockout mice emphasize the complexity of the transcription factor and genetics underlying such emotional behavior. These studies further suggest that CaMKIV may play an important role in anxiety-like behavior through its regulation of CREB since CREB mutant mice displayed alterations in emotional behavior [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B25">25</xref>].</p><p>Microarray analysis provides us the opportunity to screen for changes in thousands of genes at the same time [<xref ref-type="bibr" rid="B31">31</xref>] and this technology was applied to several studies of gene expression ranging from complex clinical diseases such as schizophrenia [<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B33">33</xref>] to human cancer [<xref ref-type="bibr" rid="B34">34</xref>]. We used microarray analysis to assay the relative gene expression levels in the forebrain of <italic>CaMKIV</italic><sup>-/- </sup>and wild-type mice. We found at least 200 genes down-regulated, five of which were stress/anxiety-related genes (Table <xref ref-type="table" rid="T1">1</xref>). Of these genes, two were neuroendocrine hormones; vasopressin and oxytocin. Mice lacking the vasopressin VIa receptor exhibit markedly reduced anxiety-like behavior [<xref ref-type="bibr" rid="B35">35</xref>] while mice lacking oxytocin display elevated anxiety-like behavior [<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B37">37</xref>] and lack stress-induced analgesia [<xref ref-type="bibr" rid="B24">24</xref>]. Interestingly, other genes found to be reduced in <italic>CaMKIV</italic><sup>-/- </sup>mice include the intracellular transportor gene, transthyretin; secretory vesicle protein, synaptotagmin 1, and a gap junction protein, connexin 43. The down-regulation of these genes suggests that the deletion of CaMKIV may affect the expression of genes involved in the regulation of presynaptic terminals and its structure. These genes are shown to be anxiety/stress related and may have other roles in addition to anxiety. The GeneChip data included in this study may help us to find a mechanism for the role of CaMKIV in anxiety and such a mechanism may include oxytocin.</p><p>Of interest, accumulating evidence suggests that oxytocin possesses anxiolytic properties and is important for stress-induced analgesia [<xref ref-type="bibr" rid="B37">37</xref>-<xref ref-type="bibr" rid="B39">39</xref>]. Oxytocin in the amygdala is essential for social recognition and the control of anxiety [<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B40">40</xref>] and central administration of oxytocin is anxiolytic and attenuates the stress response. <italic>CaMKIV</italic><sup>-/- </sup>mice, with reduced oxytocin levels, display a lack of stress-induced analgesia. Contrary to observations in oxytocin deficient mice [<xref ref-type="bibr" rid="B37">37</xref>-<xref ref-type="bibr" rid="B39">39</xref>], which displayed heightened anxiety behaviors, the present data showed that <italic>CaMKIV</italic><sup>-/- </sup>mice display lower anxiety-like behaviors. Our findings imply that changes in oxytocin expression may contribute to the changes in anxiety level of <italic>CaMKIV</italic><sup>-/- </sup>mice. Thus, it appears that CaMKIV may regulate the expression of many anxiety-related genes, including oxytocin, but that this regulation cannot solely account for the behavioral phenotype. While future studies are needed to thoroughly characterize changes in gene expression that result from the deletion of CaMKIV and how these changes affect behavioral phenotypes, our initial GeneChip data provides a good starting point for the dissection of molecular changes responsible for the anxiety phenotype of <italic>CaMKIV</italic><sup>-/- </sup>mice.</p><p>Our results suggest that a nuclear protein kinase, with broad forebrain distribution and the ability to affect gene expression through the activation of CREB, plays a role in anxiety-like behavior and that modulation of CaMKIV activity may prove useful in modifying anxious behavior. Future studies are needed to elucidate the role of CaMKIV in the molecular changes involved in the modulation of anxiety-like behaviors.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>The authors would like to thank Dr. Talal Chatila for the generous gift of <italic>CaMKIV</italic><sup>-/- </sup>mice. This work was supported by grants from the EJLB-CIHR Michael Smith Chair in Neurosciences and Mental Health in Canada and Canada Research Chair.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>West</surname><given-names>AE</given-names></name><name><surname>Griffith</surname><given-names>EC</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name></person-group><article-title>Regulation of transcription factors by neuronal activity</article-title><source>Nat Rev Neurosci</source><year>2002</year><volume>3</volume><fpage>921</fpage><lpage>931</lpage><pub-id pub-id-type="pmid">12461549</pub-id><pub-id pub-id-type="doi">10.1038/nrn987</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bourtchuladze</surname><given-names>R</given-names></name><name><surname>Frenguelli</surname><given-names>B</given-names></name><name><surname>Blendy</surname><given-names>J</given-names></name><name><surname>Cioffi</surname><given-names>D</given-names></name><name><surname>Schutz</surname><given-names>G</given-names></name><name><surname>Silva</surname><given-names>AJ</given-names></name></person-group><article-title>Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein</article-title><source>Cell</source><year>1994</year><volume>79</volume><fpage>59</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">7923378</pub-id><pub-id pub-id-type="doi">10.1016/0092-8674(94)90400-6</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Josselyn</surname><given-names>SA</given-names></name><name><surname>Shi</surname><given-names>C</given-names></name><name><surname>Carlezon</surname><given-names>WAJ</given-names></name><name><surname>Neve</surname><given-names>RL</given-names></name><name><surname>Nestler</surname><given-names>EJ</given-names></name><name><surname>Davis</surname><given-names>M</given-names></name></person-group><article-title>Long-term memory is facilitated by cAMP response element-binding protein overexpression in the amygdala</article-title><source>J Neurosci</source><year>2001</year><volume>21</volume><fpage>2404</fpage><lpage>2412</lpage><pub-id pub-id-type="pmid">11264314</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Impey</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>DM</given-names></name><name><surname>Obrietan</surname><given-names>K</given-names></name><name><surname>Donahue</surname><given-names>R</given-names></name><name><surname>Wade</surname><given-names>C</given-names></name><name><surname>Storm</surname><given-names>DR</given-names></name></person-group><article-title>Stimulation of cAMP response element (CRE)-mediated transcription during contextual learning</article-title><source>Nat Neurosci</source><year>1998</year><volume>1</volume><fpage>595</fpage><lpage>601</lpage><pub-id pub-id-type="pmid">10196567</pub-id><pub-id pub-id-type="doi">10.1038/2830</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Valverde</surname><given-names>O</given-names></name><name><surname>Mantamadiotis</surname><given-names>T</given-names></name><name><surname>Torrecilla</surname><given-names>M</given-names></name><name><surname>Ugedo</surname><given-names>L</given-names></name><name><surname>Pineda</surname><given-names>J</given-names></name><name><surname>Bleckmann</surname><given-names>S</given-names></name><name><surname>Gass</surname><given-names>P</given-names></name><name><surname>Kretz</surname><given-names>O</given-names></name><name><surname>Mitchell</surname><given-names>JM</given-names></name><name><surname>Schutz</surname><given-names>G</given-names></name><name><surname>Maldonado</surname><given-names>R</given-names></name></person-group><article-title>Modulation of anxiety-like behavior and morphine dependence in CREB-deficient mice</article-title><source>Neuropsychopharmacology</source><year>2004</year><volume>29</volume><fpage>1122</fpage><lpage>1133</lpage><pub-id pub-id-type="pmid">15029152</pub-id><pub-id pub-id-type="doi">10.1038/sj.npp.1300416</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maldonado</surname><given-names>R</given-names></name><name><surname>Smadja</surname><given-names>C</given-names></name><name><surname>Mazzucchelli</surname><given-names>C</given-names></name><name><surname>Sassone-Corsi</surname><given-names>P</given-names></name></person-group><article-title>Altered emotional and locomotor responses in mice deficient in the transcription factor CREM</article-title><source>Proc Natl Acad Sci U S A</source><year>1999</year><volume>96</volume><fpage>14094</fpage><lpage>14099</lpage><pub-id pub-id-type="pmid">10570204</pub-id><pub-id pub-id-type="doi">10.1073/pnas.96.24.14094</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barrot</surname><given-names>M</given-names></name><name><surname>Olivier</surname><given-names>JD</given-names></name><name><surname>Perrotti</surname><given-names>LI</given-names></name><name><surname>DiLeone</surname><given-names>RJ</given-names></name><name><surname>Berton</surname><given-names>O</given-names></name><name><surname>Eisch</surname><given-names>AJ</given-names></name><name><surname>Impey</surname><given-names>S</given-names></name><name><surname>Storm</surname><given-names>DR</given-names></name><name><surname>Neve</surname><given-names>RL</given-names></name><name><surname>Yin</surname><given-names>JC</given-names></name><name><surname>Zachariou</surname><given-names>V</given-names></name><name><surname>Nestler</surname><given-names>EJ</given-names></name></person-group><article-title>CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli</article-title><source>Proc Natl Acad Sci U S A</source><year>2002</year><volume>99</volume><fpage>11435</fpage><lpage>11440</lpage><pub-id pub-id-type="pmid">12165570</pub-id><pub-id pub-id-type="doi">10.1073/pnas.172091899</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nibuya</surname><given-names>M</given-names></name><name><surname>Nestler</surname><given-names>EJ</given-names></name><name><surname>Duman</surname><given-names>RS</given-names></name></person-group><article-title>Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus</article-title><source>J Neurosci</source><year>1996</year><volume>16</volume><fpage>2365</fpage><lpage>2372</lpage><pub-id pub-id-type="pmid">8601816</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shaywitz</surname><given-names>AJ</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name></person-group><article-title>CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals</article-title><source>Annu Rev Biochem</source><year>1999</year><volume>68</volume><fpage>821</fpage><lpage>861</lpage><pub-id pub-id-type="pmid">10872467</pub-id><pub-id pub-id-type="doi">10.1146/annurev.biochem.68.1.821</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Okuno</surname><given-names>S</given-names></name><name><surname>Sato</surname><given-names>F</given-names></name><name><surname>Fujisawa</surname><given-names>H</given-names></name></person-group><article-title>An immunohistochemical study of Ca2+/calmodulin-dependent protein kinase IV in the rat central nervous system: light and electron microscopic observations</article-title><source>Neuroscience</source><year>1995</year><volume>68</volume><fpage>181</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">7477923</pub-id><pub-id pub-id-type="doi">10.1016/0306-4522(95)00092-W</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matthews</surname><given-names>RP</given-names></name><name><surname>Guthrie</surname><given-names>CR</given-names></name><name><surname>Wailes</surname><given-names>LM</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Means</surname><given-names>AR</given-names></name><name><surname>McKnight</surname><given-names>GS</given-names></name></person-group><article-title>Calcium/calmodulin-dependent protein kinase types II and IV differentially regulate CREB-dependent gene expression</article-title><source>Mol Cell Biol</source><year>1994</year><volume>14</volume><fpage>6107</fpage><lpage>6116</lpage><pub-id pub-id-type="pmid">8065343</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kasahara</surname><given-names>J</given-names></name><name><surname>Fukunaga</surname><given-names>K</given-names></name><name><surname>Miyamoto</surname><given-names>E</given-names></name></person-group><article-title>Differential effects of a calcineurin inhibitor on glutamate-induced phosphorylation of Ca2+/calmodulin-dependent protein kinases in cultured rat hippocampal neurons</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>9061</fpage><lpage>9067</lpage><pub-id pub-id-type="pmid">10085155</pub-id><pub-id pub-id-type="doi">10.1074/jbc.274.13.9061</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>F</given-names></name><name><surname>Qiu</surname><given-names>CS</given-names></name><name><surname>Liauw</surname><given-names>J</given-names></name><name><surname>Robinson</surname><given-names>DA</given-names></name><name><surname>Ho</surname><given-names>N</given-names></name><name><surname>Chatila</surname><given-names>T</given-names></name><name><surname>Zhuo</surname><given-names>M</given-names></name></person-group><article-title>Calcium calmodulin-dependent protein kinase IV is required for fear memory</article-title><source>Nat Neurosci</source><year>2002</year><volume>5</volume><fpage>573</fpage><lpage>579</lpage><pub-id pub-id-type="pmid">12006982</pub-id><pub-id pub-id-type="doi">10.1038/nn855</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamamori</surname><given-names>E</given-names></name><name><surname>Asai</surname><given-names>M</given-names></name><name><surname>Yoshida</surname><given-names>M</given-names></name><name><surname>Takano</surname><given-names>K</given-names></name><name><surname>Itoi</surname><given-names>K</given-names></name><name><surname>Oiso</surname><given-names>Y</given-names></name><name><surname>Iwasaki</surname><given-names>Y</given-names></name></person-group><article-title>Calcium/calmodulin kinase IV pathway is involved in the transcriptional regulation of the corticotropin-releasing hormone gene promoter in neuronal cells</article-title><source>J Mol Endocrinol</source><year>2004</year><volume>33</volume><fpage>639</fpage><lpage>649</lpage><pub-id pub-id-type="pmid">15591024</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>N</given-names></name><name><surname>Liauw</surname><given-names>JA</given-names></name><name><surname>Blaeser</surname><given-names>F</given-names></name><name><surname>Wei</surname><given-names>F</given-names></name><name><surname>Hanissian</surname><given-names>S</given-names></name><name><surname>Muglia</surname><given-names>LM</given-names></name><name><surname>Wozniak</surname><given-names>DF</given-names></name><name><surname>Nardi</surname><given-names>A</given-names></name><name><surname>Arvin</surname><given-names>KL</given-names></name><name><surname>Holtzman</surname><given-names>DM</given-names></name><name><surname>Linden</surname><given-names>DJ</given-names></name><name><surname>Zhuo</surname><given-names>M</given-names></name><name><surname>Muglia</surname><given-names>LJ</given-names></name><name><surname>Chatila</surname><given-names>TA</given-names></name></person-group><article-title>Impaired synaptic plasticity and cAMP response element-binding protein activation in Ca2+/calmodulin-dependent protein kinase type IV/Gr-deficient mice</article-title><source>J Neurosci</source><year>2000</year><volume>20</volume><fpage>6459</fpage><lpage>6472</lpage><pub-id pub-id-type="pmid">10964952</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ko</surname><given-names>SW</given-names></name><name><surname>Chatila</surname><given-names>T</given-names></name><name><surname>Zhuo</surname><given-names>M</given-names></name></person-group><article-title>Contribution of CaMKIV to injury and fear- induced ultrasonic vocalizations in adult mice</article-title><source>Mol Pain</source><year>2005</year><volume>1</volume><fpage>10</fpage><pub-id pub-id-type="pmid">15813959</pub-id><pub-id pub-id-type="doi">10.1186/1744-8069-1-10</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lister</surname><given-names>RG</given-names></name></person-group><article-title>The use of a plus-maze to measure anxiety in the mouse</article-title><source>Psychopharmacology (Berl)</source><year>1987</year><volume>92</volume><fpage>180</fpage><lpage>185</lpage><pub-id pub-id-type="pmid">3110839</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>GW</given-names></name><name><surname>Aubry</surname><given-names>JM</given-names></name><name><surname>Dellu</surname><given-names>F</given-names></name><name><surname>Contarino</surname><given-names>A</given-names></name><name><surname>Bilezikjian</surname><given-names>LM</given-names></name><name><surname>Gold</surname><given-names>LH</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Marchuk</surname><given-names>Y</given-names></name><name><surname>Hauser</surname><given-names>C</given-names></name><name><surname>Bentley</surname><given-names>CA</given-names></name><name><surname>Sawchenko</surname><given-names>PE</given-names></name><name><surname>Koob</surname><given-names>GF</given-names></name><name><surname>Vale</surname><given-names>W</given-names></name><name><surname>Lee</surname><given-names>KF</given-names></name></person-group><article-title>Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development</article-title><source>Neuron</source><year>1998</year><volume>20</volume><fpage>1093</fpage><lpage>1102</lpage><pub-id pub-id-type="pmid">9655498</pub-id><pub-id pub-id-type="doi">10.1016/S0896-6273(00)80491-2</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crawley</surname><given-names>J</given-names></name><name><surname>Goodwin</surname><given-names>FK</given-names></name></person-group><article-title>Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines</article-title><source>Pharmacol Biochem Behav</source><year>1980</year><volume>13</volume><fpage>167</fpage><lpage>170</lpage><pub-id pub-id-type="pmid">6106204</pub-id><pub-id pub-id-type="doi">10.1016/0091-3057(80)90067-2</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kliethermes</surname><given-names>CL</given-names></name></person-group><article-title>Anxiety-like behaviors following chronic ethanol exposure</article-title><source>Neurosci Biobehav Rev</source><year>2005</year><volume>28</volume><fpage>837</fpage><lpage>850</lpage><pub-id pub-id-type="pmid">15642625</pub-id><pub-id pub-id-type="doi">10.1016/j.neubiorev.2004.11.001</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Belzung</surname><given-names>C</given-names></name><name><surname>Le Pape</surname><given-names>G</given-names></name></person-group><article-title>Comparison of different behavioral test situations used in psychopharmacology for measurement of anxiety</article-title><source>Physiol Behav</source><year>1994</year><volume>56</volume><fpage>623</fpage><lpage>628</lpage><pub-id pub-id-type="pmid">7972418</pub-id><pub-id pub-id-type="doi">10.1016/0031-9384(94)90311-5</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Gaalen</surname><given-names>MM</given-names></name><name><surname>Steckler</surname><given-names>T</given-names></name></person-group><article-title>Behavioural analysis of four mouse strains in an anxiety test battery</article-title><source>Behav Brain Res</source><year>2000</year><volume>115</volume><fpage>95</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">10996412</pub-id><pub-id pub-id-type="doi">10.1016/S0166-4328(00)00240-0</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bale</surname><given-names>TL</given-names></name><name><surname>Contarino</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>GW</given-names></name><name><surname>Chan</surname><given-names>R</given-names></name><name><surname>Gold</surname><given-names>LH</given-names></name><name><surname>Sawchenko</surname><given-names>PE</given-names></name><name><surname>Koob</surname><given-names>GF</given-names></name><name><surname>Vale</surname><given-names>WW</given-names></name><name><surname>Lee</surname><given-names>KF</given-names></name></person-group><article-title>Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress</article-title><source>Nat Genet</source><year>2000</year><volume>24</volume><fpage>410</fpage><lpage>414</lpage><pub-id pub-id-type="pmid">10742108</pub-id><pub-id pub-id-type="doi">10.1038/74263</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>DA</given-names></name><name><surname>Wei</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>GD</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Vogt</surname><given-names>SK</given-names></name><name><surname>Muglia</surname><given-names>LJ</given-names></name><name><surname>Zhuo</surname><given-names>M</given-names></name></person-group><article-title>Oxytocin mediates stress-induced analgesia in adult mice</article-title><source>J Physiol</source><year>2002</year><volume>540</volume><fpage>593</fpage><lpage>606</lpage><pub-id pub-id-type="pmid">11956346</pub-id><pub-id pub-id-type="doi">10.1113/jphysiol.2001.013492</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barrot</surname><given-names>M</given-names></name><name><surname>Wallace</surname><given-names>DL</given-names></name><name><surname>Bolanos</surname><given-names>CA</given-names></name><name><surname>Graham</surname><given-names>DL</given-names></name><name><surname>Perrotti</surname><given-names>LI</given-names></name><name><surname>Neve</surname><given-names>RL</given-names></name><name><surname>Chambliss</surname><given-names>H</given-names></name><name><surname>Yin</surname><given-names>JC</given-names></name><name><surname>Nestler</surname><given-names>EJ</given-names></name></person-group><article-title>Regulation of anxiety and initiation of sexual behavior by CREB in the nucleus accumbens</article-title><source>Proc Natl Acad Sci U S A</source><year>2005</year><volume>102</volume><fpage>8357</fpage><lpage>8362</lpage><pub-id pub-id-type="pmid">15923261</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0500587102</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>JN</given-names></name><name><surname>Young</surname><given-names>LJ</given-names></name><name><surname>Hearn</surname><given-names>EF</given-names></name><name><surname>Matzuk</surname><given-names>MM</given-names></name><name><surname>Insel</surname><given-names>TR</given-names></name><name><surname>Winslow</surname><given-names>JT</given-names></name></person-group><article-title>Social amnesia in mice lacking the oxytocin gene</article-title><source>Nat Genet</source><year>2000</year><volume>25</volume><fpage>284</fpage><lpage>288</lpage><pub-id pub-id-type="pmid">10888874</pub-id><pub-id pub-id-type="doi">10.1038/77040</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Winslow</surname><given-names>JT</given-names></name><name><surname>Hearn</surname><given-names>EF</given-names></name><name><surname>Ferguson</surname><given-names>J</given-names></name><name><surname>Young</surname><given-names>LJ</given-names></name><name><surname>Matzuk</surname><given-names>MM</given-names></name><name><surname>Insel</surname><given-names>TR</given-names></name></person-group><article-title>Infant vocalization, adult aggression, and fear behavior of an oxytocin null mutant mouse</article-title><source>Horm Behav</source><year>2000</year><volume>37</volume><fpage>145</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">10753584</pub-id><pub-id pub-id-type="doi">10.1006/hbeh.1999.1566</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Enslen</surname><given-names>H</given-names></name><name><surname>Tokumitsu</surname><given-names>H</given-names></name><name><surname>Stork</surname><given-names>PJ</given-names></name><name><surname>Davis</surname><given-names>RJ</given-names></name><name><surname>Soderling</surname><given-names>TR</given-names></name></person-group><article-title>Regulation of mitogen-activated protein kinases by a calcium/calmodulin-dependent protein kinase cascade</article-title><source>Proc Natl Acad Sci U S A</source><year>1996</year><volume>93</volume><fpage>10803</fpage><lpage>10808</lpage><pub-id pub-id-type="pmid">8855261</pub-id><pub-id pub-id-type="doi">10.1073/pnas.93.20.10803</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>GY</given-names></name><name><surname>Deisseroth</surname><given-names>K</given-names></name><name><surname>Tsien</surname><given-names>RW</given-names></name></person-group><article-title>Activity-dependent CREB phosphorylation: convergence of a fast, sensitive calmodulin kinase pathway and a slow, less sensitive mitogen-activated protein kinase pathway</article-title><source>Proc Natl Acad Sci U S A</source><year>2001</year><volume>98</volume><fpage>2808</fpage><lpage>2813</lpage><pub-id pub-id-type="pmid">11226322</pub-id><pub-id pub-id-type="doi">10.1073/pnas.051634198</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tiraboschi</surname><given-names>E</given-names></name><name><surname>Tardito</surname><given-names>D</given-names></name><name><surname>Kasahara</surname><given-names>J</given-names></name><name><surname>Moraschi</surname><given-names>S</given-names></name><name><surname>Pruneri</surname><given-names>P</given-names></name><name><surname>Gennarelli</surname><given-names>M</given-names></name><name><surname>Racagni</surname><given-names>G</given-names></name><name><surname>Popoli</surname><given-names>M</given-names></name></person-group><article-title>Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades</article-title><source>Neuropsychopharmacology</source><year>2004</year><volume>29</volume><fpage>1831</fpage><lpage>1840</lpage><pub-id pub-id-type="pmid">15138445</pub-id><pub-id pub-id-type="doi">10.1038/sj.npp.1300488</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>PO</given-names></name><name><surname>Botstein</surname><given-names>D</given-names></name></person-group><article-title>Exploring the new world of the genome with DNA microarrays</article-title><source>Nat Genet</source><year>1999</year><volume>21</volume><fpage>33</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">9915498</pub-id><pub-id pub-id-type="doi">10.1038/4462</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miyakawa</surname><given-names>T</given-names></name><name><surname>Leiter</surname><given-names>LM</given-names></name><name><surname>Gerber</surname><given-names>DJ</given-names></name><name><surname>Gainetdinov</surname><given-names>RR</given-names></name><name><surname>Sotnikova</surname><given-names>TD</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name><name><surname>Caron</surname><given-names>MG</given-names></name><name><surname>Tonegawa</surname><given-names>S</given-names></name></person-group><article-title>Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia</article-title><source>Proc Natl Acad Sci U S A</source><year>2003</year><volume>100</volume><fpage>8987</fpage><lpage>8992</lpage><pub-id pub-id-type="pmid">12851457</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1432926100</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mirnics</surname><given-names>K</given-names></name><name><surname>Middleton</surname><given-names>FA</given-names></name><name><surname>Marquez</surname><given-names>A</given-names></name><name><surname>Lewis</surname><given-names>DA</given-names></name><name><surname>Levitt</surname><given-names>P</given-names></name></person-group><article-title>Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex</article-title><source>Neuron</source><year>2000</year><volume>28</volume><fpage>53</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">11086983</pub-id><pub-id pub-id-type="doi">10.1016/S0896-6273(00)00085-4</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alizadeh</surname><given-names>AA</given-names></name><name><surname>Eisen</surname><given-names>MB</given-names></name><name><surname>Davis</surname><given-names>RE</given-names></name><name><surname>Ma</surname><given-names>C</given-names></name><name><surname>Lossos</surname><given-names>IS</given-names></name><name><surname>Rosenwald</surname><given-names>A</given-names></name><name><surname>Boldrick</surname><given-names>JC</given-names></name><name><surname>Sabet</surname><given-names>H</given-names></name><name><surname>Tran</surname><given-names>T</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Powell</surname><given-names>JI</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Marti</surname><given-names>GE</given-names></name><name><surname>Moore</surname><given-names>T</given-names></name><name><surname>Hudson</surname><given-names>JJ</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Lewis</surname><given-names>DB</given-names></name><name><surname>Tibshirani</surname><given-names>R</given-names></name><name><surname>Sherlock</surname><given-names>G</given-names></name><name><surname>Chan</surname><given-names>WC</given-names></name><name><surname>Greiner</surname><given-names>TC</given-names></name><name><surname>Weisenburger</surname><given-names>DD</given-names></name><name><surname>Armitage</surname><given-names>JO</given-names></name><name><surname>Warnke</surname><given-names>R</given-names></name><name><surname>Levy</surname><given-names>R</given-names></name><name><surname>Wilson</surname><given-names>W</given-names></name><name><surname>Grever</surname><given-names>MR</given-names></name><name><surname>Byrd</surname><given-names>JC</given-names></name><name><surname>Botstein</surname><given-names>D</given-names></name><name><surname>Brown</surname><given-names>PO</given-names></name><name><surname>Staudt</surname><given-names>LM</given-names></name></person-group><article-title>Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling</article-title><source>Nature</source><year>2000</year><volume>403</volume><fpage>503</fpage><lpage>511</lpage><pub-id pub-id-type="pmid">10676951</pub-id><pub-id pub-id-type="doi">10.1038/35000501</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bielsky</surname><given-names>IF</given-names></name><name><surname>Hu</surname><given-names>SB</given-names></name><name><surname>Szegda</surname><given-names>KL</given-names></name><name><surname>Westphal</surname><given-names>H</given-names></name><name><surname>Young</surname><given-names>LJ</given-names></name></person-group><article-title>Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice</article-title><source>Neuropsychopharmacology</source><year>2004</year><volume>29</volume><fpage>483</fpage><lpage>493</lpage><pub-id pub-id-type="pmid">14647484</pub-id><pub-id pub-id-type="doi">10.1038/sj.npp.1300360</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bale</surname><given-names>TL</given-names></name><name><surname>Davis</surname><given-names>AM</given-names></name><name><surname>Auger</surname><given-names>AP</given-names></name><name><surname>Dorsa</surname><given-names>DM</given-names></name><name><surname>McCarthy</surname><given-names>MM</given-names></name></person-group><article-title>CNS region-specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior</article-title><source>J Neurosci</source><year>2001</year><volume>21</volume><fpage>2546</fpage><lpage>2552</lpage><pub-id pub-id-type="pmid">11264328</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amico</surname><given-names>JA</given-names></name><name><surname>Mantella</surname><given-names>RC</given-names></name><name><surname>Vollmer</surname><given-names>RR</given-names></name><name><surname>Li</surname><given-names>X</given-names></name></person-group><article-title>Anxiety and stress responses in female oxytocin deficient mice</article-title><source>J Neuroendocrinol</source><year>2004</year><volume>16</volume><fpage>319</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">15089969</pub-id><pub-id pub-id-type="doi">10.1111/j.0953-8194.2004.01161.x</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Windle</surname><given-names>RJ</given-names></name><name><surname>Shanks</surname><given-names>N</given-names></name><name><surname>Lightman</surname><given-names>SL</given-names></name><name><surname>Ingram</surname><given-names>CD</given-names></name></person-group><article-title>Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats</article-title><source>Endocrinology</source><year>1997</year><volume>138</volume><fpage>2829</fpage><lpage>2834</lpage><pub-id pub-id-type="pmid">9202224</pub-id><pub-id pub-id-type="doi">10.1210/en.138.7.2829</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Windle</surname><given-names>RJ</given-names></name><name><surname>Kershaw</surname><given-names>YM</given-names></name><name><surname>Shanks</surname><given-names>N</given-names></name><name><surname>Wood</surname><given-names>SA</given-names></name><name><surname>Lightman</surname><given-names>SL</given-names></name><name><surname>Ingram</surname><given-names>CD</given-names></name></person-group><article-title>Oxytocin attenuates stress-induced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamo-pituitary-adrenal activity</article-title><source>J Neurosci</source><year>2004</year><volume>24</volume><fpage>2974</fpage><lpage>2982</lpage><pub-id pub-id-type="pmid">15044536</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3432-03.2004</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>JN</given-names></name><name><surname>Aldag</surname><given-names>JM</given-names></name><name><surname>Insel</surname><given-names>TR</given-names></name><name><surname>Young</surname><given-names>LJ</given-names></name></person-group><article-title>Oxytocin in the medial amygdala is essential for social recognition in the mouse</article-title><source>J Neurosci</source><year>2001</year><volume>21</volume><fpage>8278</fpage><lpage>8285</lpage><pub-id pub-id-type="pmid">11588199</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sousa</surname><given-names>JC</given-names></name><name><surname>Grandela</surname><given-names>C</given-names></name><name><surname>Fernandez-Ruiz</surname><given-names>J</given-names></name><name><surname>de Miguel</surname><given-names>R</given-names></name><name><surname>de Sousa</surname><given-names>L</given-names></name><name><surname>Magalhaes</surname><given-names>AI</given-names></name><name><surname>Saraiva</surname><given-names>MJ</given-names></name><name><surname>Sousa</surname><given-names>N</given-names></name><name><surname>Palha</surname><given-names>JA</given-names></name></person-group><article-title>Transthyretin is involved in depression-like behaviour and exploratory activity</article-title><source>J Neurochem</source><year>2004</year><volume>88</volume><fpage>1052</fpage><lpage>1058</lpage><pub-id pub-id-type="pmid">15009661</pub-id><pub-id pub-id-type="doi">10.1046/j.1471-4159.2003.02309.x</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Theis</surname><given-names>M</given-names></name><name><surname>Jauch</surname><given-names>R</given-names></name><name><surname>Zhuo</surname><given-names>L</given-names></name><name><surname>Speidel</surname><given-names>D</given-names></name><name><surname>Wallraff</surname><given-names>A</given-names></name><name><surname>Doring</surname><given-names>B</given-names></name><name><surname>Frisch</surname><given-names>C</given-names></name><name><surname>Sohl</surname><given-names>G</given-names></name><name><surname>Teubner</surname><given-names>B</given-names></name><name><surname>Euwens</surname><given-names>C</given-names></name><name><surname>Huston</surname><given-names>J</given-names></name><name><surname>Steinhauser</surname><given-names>C</given-names></name><name><surname>Messing</surname><given-names>A</given-names></name><name><surname>Heinemann</surname><given-names>U</given-names></name><name><surname>Willecke</surname><given-names>K</given-names></name></person-group><article-title>Accelerated hippocampal spreading depression and enhanced locomotory activity in mice with astrocyte-directed inactivation of connexin43</article-title><source>J Neurosci</source><year>2003</year><volume>23</volume><fpage>766</fpage><lpage>776</lpage><pub-id pub-id-type="pmid">12574405</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Geppert</surname><given-names>M</given-names></name><name><surname>Goda</surname><given-names>Y</given-names></name><name><surname>Hammer</surname><given-names>RE</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Rosahl</surname><given-names>TW</given-names></name><name><surname>Stevens</surname><given-names>CF</given-names></name><name><surname>Sudhof</surname><given-names>TC</given-names></name></person-group><article-title>Synaptotagmin I: a major Ca2+ sensor for transmitter release at a central synapse</article-title><source>Cell</source><year>1994</year><volume>79</volume><fpage>717</fpage><lpage>727</lpage><pub-id pub-id-type="pmid">7954835</pub-id><pub-id pub-id-type="doi">10.1016/0092-8674(94)90556-8</pub-id></citation></ref></ref-list></back></article> 